Source: International Congress 2016 – Mechanisms of disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Donato Lacedonia (Molfetta, Italy), Donato Lacedonia, Grazia Pia Palladino, Maria Pia Foschino Barbaro, Cristina Colanardi, Piera Soccio, Incoronata Caccavo, Giovanna E. Carpagnano. Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects. Eur Respir J 2016; 48: Suppl. 60, 4656

Member's Comments

No comment yet.

Related content which might interest you: Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 The first U-BIOPRED sputum handprint of severe asthma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 TSLP as biomarker in asthma patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Plasma levels of TIPM-2 in patients with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Expression of mRNA chemokine and their receptors in nasopharingeal brush-biopsies represents age of bronchial asthma patients Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Serum periostin in healthy controls and patients with asthma and chronic rhinosinusitis; data from the Swedish GA(2)LEN population study Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Differential bronchial epithelial gene expression in COPD versus controls Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016